Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Idcases
|
February 15, 2020
Intravenous (IV) cefazolin with oral probenecid: A novel daily regimen for the management of Methicillin Sensitive Staphylococcus aureus (MSSA) bacteremia in a patient with renal dysfunction
Sunish Shah, Marjorie Golden, Jeffrey E Topal, et al.
Anaerobe
|
May 9, 2021
Three is a crowd: Clinical outcomes of a twice daily versus a thrice daily metronidazole dosing strategy from a multicenter study
Sunish Shah, Kathleen Adams, Jacob Merwede, et al.
Nutrition and Metabolic Insights
|
July 20, 2019
Impact of the Time to Initiation of Parenteral Nutrition on Patient Outcomes in Critically Ill Adults
Sunish Shah, James M Hollands, Laura Pontiggia, et al.
Antimicrobial Agents and Chemotherapy
|
May 28, 2026
Evaluation of combination therapy duration for endocarditis secondary to Enterobacterales
Sunish Shah, Jake Smith, Brandon J Smith, et al.
Expert Opinion on Pharmacotherapy
|
September 21, 2025
Novel beta-lactamase inhibitors with cefepime: where do they fit in clinical practice?
Sunish Shah, Sahil Angelo, Brandon J Smith, et al.
Open Forum Infectious Diseases
|
June 18, 2021
A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis
Sunish Shah, David P Nicolau, Dayna McManus, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2024
Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents
Yingsi Fang, Lloyd G Clarke, Brandon J Smith, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2026
Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections
Sunish Shah, Rachel V Marini, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2020
A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort
Tyler W Ackley, Dayna McManus, Jeffrey E Topal, et al.
Infection
|
March 27, 2025
Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infections
Sunish Shah, Brianne Slaven, Lloyd G Clarke, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Idcases
|
February 15, 2020
Intravenous (IV) cefazolin with oral probenecid: A novel daily regimen for the management of Methicillin Sensitive Staphylococcus aureus (MSSA) bacteremia in a patient with renal dysfunction
Sunish Shah, Marjorie Golden, Jeffrey E Topal, et al.
Anaerobe
|
May 9, 2021
Three is a crowd: Clinical outcomes of a twice daily versus a thrice daily metronidazole dosing strategy from a multicenter study
Sunish Shah, Kathleen Adams, Jacob Merwede, et al.
Nutrition and Metabolic Insights
|
July 20, 2019
Impact of the Time to Initiation of Parenteral Nutrition on Patient Outcomes in Critically Ill Adults
Sunish Shah, James M Hollands, Laura Pontiggia, et al.
Antimicrobial Agents and Chemotherapy
|
May 28, 2026
Evaluation of combination therapy duration for endocarditis secondary to Enterobacterales
Sunish Shah, Jake Smith, Brandon J Smith, et al.
Expert Opinion on Pharmacotherapy
|
September 21, 2025
Novel beta-lactamase inhibitors with cefepime: where do they fit in clinical practice?
Sunish Shah, Sahil Angelo, Brandon J Smith, et al.
Open Forum Infectious Diseases
|
June 18, 2021
A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis
Sunish Shah, David P Nicolau, Dayna McManus, et al.
Antimicrobial Agents and Chemotherapy
|
September 5, 2024
Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents
Yingsi Fang, Lloyd G Clarke, Brandon J Smith, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2026
Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections
Sunish Shah, Rachel V Marini, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2020
A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort
Tyler W Ackley, Dayna McManus, Jeffrey E Topal, et al.
Infection
|
March 27, 2025
Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infections
Sunish Shah, Brianne Slaven, Lloyd G Clarke, et al.
Page
of 5